Celladon Corporation Reports Fourth Quarter and Year-End 2013 Financial Results And Recent Highlights
Published: Apr 01, 2014
SAN DIEGO, March 31, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced financial results for the quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.